These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 33928571)
1. siRNA Design and GalNAc-Empowered Hepatic Targeted Delivery. Lu M; Zhang M; Hu B; Huang Y Methods Mol Biol; 2021; 2282():77-100. PubMed ID: 33928571 [TBL] [Abstract][Full Text] [Related]
2. Development of siRNA Therapeutics for the Treatment of Liver Diseases. Holm A; Løvendorf MB; Kauppinen S Methods Mol Biol; 2021; 2282():57-75. PubMed ID: 33928570 [TBL] [Abstract][Full Text] [Related]
3. GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics. Springer AD; Dowdy SF Nucleic Acid Ther; 2018 Jun; 28(3):109-118. PubMed ID: 29792572 [TBL] [Abstract][Full Text] [Related]
4. Investigating the pharmacodynamic durability of GalNAc-siRNA conjugates. Brown CR; Gupta S; Qin J; Racie T; He G; Lentini S; Malone R; Yu M; Matsuda S; Shulga-Morskaya S; Nair AV; Theile CS; Schmidt K; Shahraz A; Goel V; Parmar RG; Zlatev I; Schlegel MK; Nair JK; Jayaraman M; Manoharan M; Brown D; Maier MA; Jadhav V Nucleic Acids Res; 2020 Dec; 48(21):11827-11844. PubMed ID: 32808038 [TBL] [Abstract][Full Text] [Related]
5. siRNA conjugates carrying sequentially assembled trivalent N-acetylgalactosamine linked through nucleosides elicit robust gene silencing in vivo in hepatocytes. Matsuda S; Keiser K; Nair JK; Charisse K; Manoharan RM; Kretschmer P; Peng CG; V Kel'in A; Kandasamy P; Willoughby JL; Liebow A; Querbes W; Yucius K; Nguyen T; Milstein S; Maier MA; Rajeev KG; Manoharan M ACS Chem Biol; 2015 May; 10(5):1181-7. PubMed ID: 25730476 [TBL] [Abstract][Full Text] [Related]